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Abstract
Mycoplasma pneumoniae (MP) is a gram-positive bacterium most commonly associated with community-
acquired pneumonia in adults. It can also involve other systems of the body. Cardiovascular complications
include pericarditis, myocarditis, congestive cardiac failure, and, rarely, infective endocarditis. We report a
case of infective endocarditis secondary to MP infection in an adult. We treated our patient with
doxycycline, which showed significant improvement. 
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Introduction
Mycoplasma pneumoniae (MP) is a gram-positive bacterium responsible for respiratory tract infection in
children and young adults and causes mild to severe upper and lower respiratory tract infections termed
atypical pneumonia [1]. Reports suggest an incidence of 10-40% of community-acquired pneumonia in some
communities [2]. Hepatic, neurological, cardiac, and skin manifestations of MP are well recognized [1]. Other
known associated diseases with MP include Steven-Johnson syndrome, toxic epidermal necrolysis, and
erythema multiforme [3]. Limited reports in the literature exist of an association of MP with infective
endocarditis; however, patients described earlier have a history of associated heart disease [4-6]. Here, we
discuss the case of a lady who presented with fever, later diagnosed as infective endocarditis secondary to
MP infection without a preexisting heart disease in an immunocompetent individual.
Case Presentation
A 29 -year-old lady with no previous medical history presented to the emergency department after
developing a sudden-onset fever, myalgia, and weight loss for the past one month. Her history was negative
for any congenital or acquired heart disease, or any recent dental procedures. She had no history of any
intravenous drug abuse.
On physical examination, her blood pressure was 107/58 mmHg, pulse 78 beats/min, respiratory rate 18
breaths/min, and temperature 38.2°C. Her systemic examination was unremarkable and her laboratory
investigations including full blood count and inflammatory markers (including erythrocyte sedimentation
rate and C-reactive protein levels) were within the normal reference range. However, her troponin-I was
raised and an electrocardiogram showed a new left bundle branch block (Figure 1). Chest X-ray was also
normal.
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FIGURE 1: Electrocardiogram showing left bundle branch block
Three blood cultures were drawn with spacing of 30 minutes each and serologies
for Brucella, Bartonella, Coxiella, and virology were sent, which came back negative. An echocardiogram
showed large mobile vegetation of 1.8 cm attached to the pulmonary valve with no valvular destruction, and
mild reduction of left ventricular systolic function with an ejection fraction of 50% (Figure 2). We started her
on empirical antimicrobial therapy with intravenous gentamicin and vancomycin to treat infective
endocarditis. During the first week of antimicrobial treatment, the patient experienced unexplained febrile
neutropenia; however, there was no apparent cause.
FIGURE 2: Echocardiogram showing a 1.8 cm vegetation attached to the
pulmonary valve
All repeated blood cultures were consistently negative. We consulted Infectious Disease, which advised us to
stop vancomycin and to switch to teicoplanin and piperacillin-tazobactam, along with doxycycline. Due to a
failure of empiric treatment, we sent the patient's whole blood and plasma for detection of MP by gene
amplification via polymerase chain reaction, which came back negative; however, her serology was positive
for MP and we started our patient on doxycycline. The patient's fever settled as she improved clinically
following the administration of doxycycline. She was discharged to home with doxycycline therapy for a
total of two weeks and a repeat echocardiogram at follow-up after two weeks showed complete resolution of
the vegetation (Figure 3). 
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FIGURE 3: Echocardiogram showing complete resolution of the
vegetation after antibiotic therapy
Discussion
Clinical presentation of MP varies and most commonly presents as upper and lower respiratory tract
symptoms. Though extrapulmonary involvement has been identified, cardiovascular manifestations include
pericarditis, myocarditis, congestive cardiac failure, and rarely infective endocarditis [7]. It can affect almost
any organ of the body through direct invasion of bacteria or autoimmunity or immune complex
deposition [8,9]. Central nervous system manifestations are most noteworthy, especially in children. The
presence of extra-pulmonary involvement correlates to a worsened prognosis and can be seen even in the
absence of respiratory symptoms [7]. The pathogenesis of endocarditis secondary to MP infection involves
the local release of inflammatory cytokines after bacteremia [9]. As cultures are difficult to grow, the
diagnosis is based on clinical, radiological, and serological testing [10,11]. The most common organisms
involved in culture-negative infective endocarditis include Coxiella burnetii, Bartonella spp, and Tropheryma
whipplei, and are associated with a higher mortality rate [12]. Of the organisms that are linked with culture-
negative infective endocarditis, Mycoplasma spp.-associated endocarditis is most commonly observed in
patients with a preexisting cardiac condition [4-6]. 
Our patient presented with fever, raised troponin-I, and a new left bundle branch block on
electrocardiography, which gave us a clue that the source of infection is coming from the heart. Failure of
empiric antibiotic therapy for infective endocarditis prompted us to look for alternate causes of fever. We
started our patient on empirical antibiotic therapy but failed to achieve a response. However, when her
serological testing was positive for MP, we switched to doxycycline, after which her symptoms improved.
Our review of the literature revealed limited reports of infectious endocarditis secondary to MP infection. In
1980, Popat et al. described the first case ever of MP causing endocarditis in a young adult [13]. The patient
had a history of rheumatic heart disease, who then presenting with fever, lethargy, and malaise was later
diagnosed with mycoplasma endocarditis via serology. He was initially started on benzylpenicillin and
gentamycin for six weeks, later switched to oxytetracycline, to which he responded very well. Interestingly,
his transthoracic echocardiogram (TTE) did not show any vegetations [13]. However, a case reported from
Argentina by Scapini et al. showed vegetations in TTE, and the patient was started on clarithromycin after
cultures grew MP [14]. In comparison, our patient also had vegetations in his TTE and showed dynamic
clinical improvement after initiation of doxycycline, similar to a previously reported case [15].
Through this report, we further strengthen the literature regarding the association of MP with culture-
negative infective endocarditis. We believe that robust data are required to determine the true incidence of
this association. We provide evidence of the therapeutic success achieved through the doxycycline treatment
regimen.
Conclusions
MP is commonly known as a respiratory pathogen. However, it may involve other systems of the body as
well, including the cardiovascular. Rarely, it can cause culture-negative infective endocarditis. We
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